Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$4.89 - $12.27 $488 - $1,227
100 Added 0.12%
86,444 $424,000
Q3 2022

Oct 28, 2022

BUY
$8.24 - $12.56 $65,096 - $99,224
7,900 Added 10.07%
86,344 $808,000
Q2 2022

Aug 01, 2022

BUY
$7.45 - $13.84 $232,440 - $431,808
31,200 Added 66.04%
78,444 $716,000
Q1 2022

Apr 27, 2022

BUY
$9.94 - $12.65 $183,890 - $234,025
18,500 Added 64.36%
47,244 $574,000
Q4 2021

Jan 24, 2022

BUY
$11.99 - $18.14 $188,243 - $284,798
15,700 Added 120.36%
28,744 $350,000
Q3 2021

Oct 25, 2021

SELL
$11.55 - $16.06 $45,045 - $62,633
-3,900 Reduced 23.02%
13,044 $202,000
Q2 2021

Jul 21, 2021

BUY
$12.38 - $29.19 $209,766 - $494,595
16,944 New
16,944 $242,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $262M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.